• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.肺部和纵隔肿瘤患者的放射性肺炎:一项以肺气肿为重点的回顾性危险因素研究。
Br J Radiol. 2012 Feb;85(1010):135-41. doi: 10.1259/bjr/32629867. Epub 2011 Mar 8.
2
Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapy.肺氣腫是胸部放療後非小細胞肺癌合併鱗狀細胞癌患者放射性肺炎的危險因素。
Sci Rep. 2017 Jun 5;7(1):2748. doi: 10.1038/s41598-017-02739-4.
3
Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.立体定向体部放射治疗后放射性肺炎的预后价值:使用 CT 图像定量分析肺气肿的影响。
Clin Lung Cancer. 2018 Jan;19(1):e85-e90. doi: 10.1016/j.cllc.2017.05.022. Epub 2017 Jun 8.
4
Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.联合分析基线 CT 上的 V20、VS5、肺纤维化评分和患者年龄可提高局部晚期非小细胞肺癌同期放化疗后重度放射性肺炎的预测能力。
J Thorac Oncol. 2014 Jul;9(7):983-990. doi: 10.1097/JTO.0000000000000187.
5
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.非小细胞肺癌适形放疗后放射性肺炎的前瞻性研究:临床与剂量学因素分析
Radiother Oncol. 2004 May;71(2):175-81. doi: 10.1016/j.radonc.2004.02.005.
6
Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.与胸部放射治疗同时偶然使用血管紧张素转换酶抑制剂可降低放射性肺炎的风险。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):238-43. doi: 10.1016/j.ijrobp.2011.11.013. Epub 2012 Jan 31.
7
Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy.重度肺气肿患者在接受立体定向体部放射治疗后发生放射性肺炎的风险较低。
Br J Radiol. 2015 Feb;88(1046):20140596. doi: 10.1259/bjr.20140596. Epub 2014 Dec 9.
8
Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.剂量-体积参数预测诱导放化疗后手术治疗非小细胞肺癌后放射性肺炎:一项回顾性分析。
BMC Cancer. 2019 Nov 26;19(1):1144. doi: 10.1186/s12885-019-6359-9.
9
Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.肺癌患者放射性肺炎的预测因素:一项回顾性研究。
Radiother Oncol. 2003 Jun;67(3):275-83. doi: 10.1016/s0167-8140(03)00119-1.
10
Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.放射性肺炎的预后分析:局部晚期肺癌患者的碳离子放疗
Radiat Oncol. 2017 May 30;12(1):91. doi: 10.1186/s13014-017-0830-z.

引用本文的文献

1
Effect of FLASH proton therapy on primary bronchial epithelial cell organoids.FLASH质子治疗对原发性支气管上皮细胞类器官的影响。
Clin Transl Radiat Oncol. 2025 Jan 29;52:100927. doi: 10.1016/j.ctro.2025.100927. eCollection 2025 May.
2
Improper lung volume-dose parameters are risk factors for acute fatal radiation pneumonitis among esophageal cancer patients receiving chemoradiotherapy: a case-control study.不适当的肺容积-剂量参数是接受放化疗的食管癌患者发生急性致命性放射性肺炎的危险因素:一项病例对照研究。
Front Oncol. 2025 Jan 28;15:1535676. doi: 10.3389/fonc.2025.1535676. eCollection 2025.
3
Enhanced radiation sensitivity, decreased DNA damage repair, and differentiation defects in airway stem cells derived from patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者气道干细胞的辐射敏感性增强、DNA 损伤修复减少和分化缺陷。
Stem Cells Transl Med. 2024 Sep 10;13(9):927-939. doi: 10.1093/stcltm/szae043.
4
Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌放疗后患者放射性肺炎的危险因素分析
Front Oncol. 2023 Nov 7;13:1198872. doi: 10.3389/fonc.2023.1198872. eCollection 2023.
5
Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.食管癌患者放疗后放射性肺炎预测模型。
BMC Cancer. 2023 Oct 17;23(1):988. doi: 10.1186/s12885-023-11499-6.
6
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease.肺癌合并慢性阻塞性肺疾病诊断与治疗的国际专家共识
Transl Lung Cancer Res. 2023 Aug 30;12(8):1661-1701. doi: 10.21037/tlcr-23-339. Epub 2023 Aug 24.
7
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma.durvalumab 维持治疗在不可切除局部晚期非小细胞肺癌同期放化疗后肺损伤的预测因素。
Thorac Cancer. 2023 Sep;14(25):2601-2607. doi: 10.1111/1759-7714.15042. Epub 2023 Aug 2.
8
Assessing four-dimensional CT stress maps derived from patient-specific biomechanical models of the lung with pulmonary function test data in lung cancer patients.评估基于肺癌患者特定生物力学模型的四维 CT 应力图与肺功能测试数据的相关性。
Br J Radiol. 2023 Sep;96(1149):20221149. doi: 10.1259/bjr.20221149. Epub 2023 Jul 4.
9
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy.高迁移率族蛋白 B1 循环水平对接受根治性胸部放疗的非小细胞肺癌患者放射性肺炎的预测作用。
Int J Clin Oncol. 2022 Nov;27(11):1698-1705. doi: 10.1007/s10147-022-02239-0. Epub 2022 Sep 3.
10
Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer.非小细胞肺癌治疗期间放射性肺炎联合免疫治疗的研究进展
Cancer Manag Res. 2022 Aug 13;14:2469-2483. doi: 10.2147/CMAR.S374648. eCollection 2022.

本文引用的文献

1
Functional image-based radiotherapy planning for non-small cell lung cancer: A simulation study.基于功能成像的非小细胞肺癌放射治疗计划:一项模拟研究。
Radiother Oncol. 2009 Oct;93(1):32-6. doi: 10.1016/j.radonc.2009.05.018. Epub 2009 Jun 22.
2
Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors.局部晚期非小细胞肺癌的治疗建议:医生和患者因素的影响
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1376-84. doi: 10.1016/j.ijrobp.2008.10.066. Epub 2009 May 4.
3
Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.双时间点氟代脱氧葡萄糖正电子发射断层扫描用于评估非小细胞肺癌患者的淋巴结转移情况。
Ann Nucl Med. 2008 May;22(4):245-50. doi: 10.1007/s12149-007-0103-2. Epub 2008 Jun 6.
4
Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).非小细胞肺癌ⅢB期的治疗:美国胸科医师学会循证临床实践指南(第2版)
Chest. 2007 Sep;132(3 Suppl):266S-276S. doi: 10.1378/chest.07-1380.
5
Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.利用灌注成像和调强放射治疗保留晚期非小细胞肺癌患者的功能性肺组织
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1349-58. doi: 10.1016/j.ijrobp.2007.02.015. Epub 2007 Apr 18.
6
Reduction of normal lung irradiation in locally advanced non-small-cell lung cancer patients, using ventilation images for functional avoidance.在局部晚期非小细胞肺癌患者中,利用通气图像进行功能避让以减少正常肺组织受照剂量。
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):562-71. doi: 10.1016/j.ijrobp.2007.01.044. Epub 2007 Mar 29.
7
CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?立体定向体部放射治疗(SBRT)治疗肺癌后肺部放射性损伤的CT表现及临床症状:肺气肿患者也是肺癌SBRT的候选者吗?
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):483-91. doi: 10.1016/j.ijrobp.2006.05.008. Epub 2006 Aug 14.
8
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.非小细胞肺癌(NSCLC)患者放射剂量递增研究的最终毒性结果:放射性肺炎和肺纤维化的预测因素
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1075-86. doi: 10.1016/j.ijrobp.2006.01.051. Epub 2006 May 2.
9
Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.非小细胞肺癌中的放射性肺炎和肺纤维化:肺功能、预测与预防
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):5-24. doi: 10.1016/j.ijrobp.2005.03.047.
10
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.在一项近期完成的剂量递增研究中,非小细胞肺癌患者剂量学因素与放射性肺炎的相关性
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):672-82. doi: 10.1016/j.ijrobp.2005.03.026. Epub 2005 Jun 4.

肺部和纵隔肿瘤患者的放射性肺炎:一项以肺气肿为重点的回顾性危险因素研究。

Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema.

机构信息

Department of Radiology, Kagawa University, Faculty of Medicine, Kagawa, Japan.

出版信息

Br J Radiol. 2012 Feb;85(1010):135-41. doi: 10.1259/bjr/32629867. Epub 2011 Mar 8.

DOI:10.1259/bjr/32629867
PMID:21385918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3473945/
Abstract

OBJECTIVES

To evaluate the impact of pulmonary emphysema (PE) on the incidence and severity of radiation pneumonitis (RP) in patients with lung and mediastinal tumours.

METHODS

92 patients were enrolled. Involved-field radiation therapy (non-small cell carcinoma or mediastinal tumours in 69 patients; median 70 Gy) and accelerated hyperfractionation (limited disease small cell carcinoma in 23 patients; median 45 Gy) were performed. Common Terminology Criteria for Adverse Events v.3.0 was used to evaluate RP and the relationship with the percentage of pulmonary volume irradiated to >20 Gy (V20) and PE. PE was diagnosed by the presence of low-attenuation areas (LAAs) on CT scans and was classified into Grades 0-4 according to the extent of the LAAs.

RESULTS

The median follow-up time was 16 months. The 6-month cumulative incidence of RP at Grade 3 or greater was 7.7% and 34.1% in patients with a V20 of <25% and ≥25%, respectively (p=0.017). In patients with PE Grades 0, 1, 2 and 3 or greater, the incidence of RP was 16.5%, 9.1%, 8.6% and 54.0%, respectively. As the PE Grade increased, the incidence of RP also increased significantly.

CONCLUSION

The incidence and severity of RP are significantly higher in patients with a high V20 value as well as in those with severe PE.

摘要

目的

评估肺气肿(PE)对肺部和纵隔肿瘤患者放射性肺炎(RP)发生率和严重程度的影响。

方法

共纳入 92 例患者。行累及野放疗(非小细胞癌或纵隔肿瘤患者 69 例;中位剂量 70 Gy)和加速超分割放疗(局限期小细胞癌患者 23 例;中位剂量 45 Gy)。采用不良事件通用术语标准 v.3.0 评估 RP,并分析其与肺部受照 20 Gy 以上体积百分比(V20)和 PE 的关系。PE 通过 CT 扫描上低衰减区(LAAs)的存在进行诊断,并根据 LAAs 的范围分为 0-4 级。

结果

中位随访时间为 16 个月。V20<25%和≥25%的患者 6 个月时 RP 发生率≥3 级的累积发生率分别为 7.7%和 34.1%(p=0.017)。PE 0、1、2 和 3 级或更高级别的患者 RP 发生率分别为 16.5%、9.1%、8.6%和 54.0%。随着 PE 分级的增加,RP 的发生率也显著增加。

结论

V20 值较高和存在严重 PE 的患者,RP 的发生率和严重程度显著更高。